secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2025-12-23T23:59:59+00:00
Accession:  0001193125-25-331147
Event type: litigation
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos Therapeutics settles unpaid invoices with MD Anderson for $285,055
--------------------------------------------------------------------------

- Settlement resolves disputes over $285,055 in unpaid invoices under 2019 R&D agreement with MD Anderson.
- Alaunos to pay in six installments: $142,528 by Dec 30, 2025, then five monthly payments of $28,506 through May 30, 2026.
- Mutual general releases exchanged for claims related to unpaid invoices; ongoing protocol 2006-0676 excluded.
- CEO Holger Weis signed agreement on Dec 15, 2025; effective date Dec 17, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000119312525331147/0001193125-25-331147-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000119312525331147/tcrt-20251217.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-331147

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer